-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Protara Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2013 to Q4 2024.
- Protara Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$14.3M, a 29.6% decline year-over-year.
- Protara Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$49.2M, a 12.7% decline year-over-year.
- Protara Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$49.2M, a 12.7% decline from 2023.
- Protara Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$43.6M, a 35% increase from 2022.
- Protara Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$67.1M, a 41.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)